CDC recommends changes to pneumonia vaccine policy
The CDC is recommending that the decision for a patient to receive one of the vaccines for pneumococcal disease be left to doctors and patients.
Anywhere from 70 percent to 90 percent of seasonal flu-related deaths in recent years have been among people 65 years and older, according to the U.S. Centers for Disease Control and Prevention (CDC).
The elderly also need expensive high-dose flu vaccine shots that contain four times the amount of antigen compared to a regular flu shot. These vaccines are made specifically for those 65 and older since it’s well-documented that senior citizens are at a much higher risk of suffering complications from the flu.
70 Million Flu Vaccines Delayed This Year, According to CDC
Difficulty in nailing down the predominant strains this year led Sanofi Pasteur to delay production of its flu vaccine by a month.
One of the most effective flu vaccines for seniors -- the Fluzone High-Dose vaccine made by Sanofi Pasteur -- is especially hard to come by. The Fluzone High-Dose vaccine is licensed for people 65 years and older. It's effective because it has a higher dose of the antigen that strengthens the body’s immune response.
The higher antigen content offers better protection from the flu among seniors. It takes two weeks after vaccination for the Fluzone High-Dose vaccine to take full effect.
A study in the New England Journal of Medicine (NEJM) found this vaccine prevents flu about 25 percent more often among seniors. Another study found this vaccine appears to reduce hospital admissions for the flu among the elderly.
There's only one problem: vaccines for the elderly are still hard to find. There's also a shortage of the Fluzone High-Dose vaccine despite CDC announcing that nearly 170 million flu vaccine doses of all kinds from different manufacturers will be distributed in the U.S. this year. CDC claims this total will be enough to meet anticipated demand for the flu season, which normally lasts from October to February.
German lawmakers approve compulsory measles vaccine plan
Parents who can't prove their children have been vaccinated for measles by Aug. 1, 2021, will have to pay a fine of up to 2,500 euros ($2,790). Lawmakers approved the government’s bill Thursday with a majority of 459 in favor, 89 against and 105 abstentions.
What CDC is saying by washing its hands of the shortage is the supply chain's problem, and not the supply. It's a problem that keeps resurfacing every year, and every year, health authorities say the problem's only temporary.
News reports said some areas of Colorado, Wyoming and northern Indiana are experiencing a shortage of the vaccine. Local news reports from Texas, Iowa and Maine are telling the same story: flu vaccines for the elderly -- the most vulnerable population -- remain in short supply.
are now reporting a shortage of higher-dose vaccines recommended for people 65 and older. The Port Arthur Health Department believes the shortage is likely the result of increased awareness about the importance of senior citizens getting vaccinated.
Latasha Mayon, Assistant Director of the Port Arthur Health Department, said it's very important for senior citizens to get immunized against the flu.
German lawmakers approve compulsory measles vaccine plan
Despite conflicts and crisis, Sudan is looking to bring in tourists and visitors to such places as the Royal Pyramids of Meroe. Veuer’s Mercer Morrison has the story.
"They will have the worst of it, the symptoms will be multiplied by 100 if they're not treated at least with the flu shot," she pointed out.
Health experts in Iowa are blaming their vaccine shortages on supply chain issues. Others claim the shortage is because the CDC took one month longer to decide what vaccines should be produced for this year's flu season.
“The reason for the shortage is because the CDC who makes recommendations for what strains are in the flu vaccine made a late change to the recommendation which put production behind a month,” according to one Iowa pharmacist.
in the media some pharmacies in the state don’t yet have the flu vaccine designed for seniors. State health officials said there's no hitch getting most flu vaccines. But a few specialized ones such as those for seniors were delayed by a month while experts figured out how to reformulate them for maximum value.
The shortage appears to be a temporary problem, as per health officials.
Gallery: Weather Makes You Sick, and Other Cold and Flu Myths Debunked (Provided by The Active Times)
18 Recipes That Start with a Bag of Peanut Butter Chips
Peanut butter chips add personality to any bake. Check out our favorite nutty recipes that make this ingredient the star of the show. The post 18 Recipes That Start with a Bag of Peanut Butter Chips appeared first on Taste of Home.
Sanofi completes acquisition of Protein Sciences for $ 750 million
After more than a month of waiting, Sanofi announced today that it has completed the acquisition of Protein Sciences, a US biotech company specializing in vaccines against influenza. The transaction comes as a result of its approval by the, the independent US agency responsible for controlling anti-competitive business practices.
The company - already known as one of the world leaders in the concentrated vaccine market -in what remains one of its only major operations in this sector. The French pharmaceutical giant announced $ 650 million (544 million euros), to which would be added 100 million dollars (83 million euros) additional according to "the achievement of certain objectives" as it is specified
Sanofi's executive vice president and head of Sanofi Pasteur - the group's Vaccines division - David Loew, said in the same message that the company would benefit from "the unique opportunity to complete its vaccine portfolio. influenza ".
flu vaccine With the acquisition of a private company based in Meriden, Connecticut, Sanofi aims to explore vaccine production techniques against the flu that make it possible to overcome. Protein Sciences developed and commercialized the Flubook Quadrivalent vaccine, the first recombinant protein-based, recombinantly engineered, influenza vaccine in the US.
The mission of the new entity of the Sanofi group is to develop vaccines and innovative biopharmaceutical products to save and improve health. Sanofi Pasteur, to whom Protein Sciences will report, is the world's leading producer of influenza vaccines. In 2016, Sanofi Pasteur confirmed its leadership with the production of 200 million doses of seasonal influenza vaccine, which corresponds to 40% of influenza vaccines distributed around the world.
Should I get the flu vaccine? What to know about the flu season .
It's absolutely not too late to get the flu shot, experts say.The Centers for Disease Control and Prevention is already reporting widespread activity in six states, mostly in the South and West: Alabama, California, Louisiana, Massachusetts, Nevada and South Carolina. At this time last year, no states showed widespread activity.